2 completed, 1 terminated. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
| Phase 1 | 2 | Completed 2 |
Follow Mixed Oligoastrocytoma: new trials by email Literature Review of Mixed Oligoastrocytoma trials Research Report on Mixed Oligoastrocytoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors MRI-guided laser ablation, Doxorubicin, Etoposide - Glioma, Pilocytic Astrocytoma | Phase 2 | Terminated | Washington University School of Medicine | 6 | 2015-08-14 | 2024-11-01 |
| Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma IL13-PE38QQR, targeted fusion protein therapy, surgery - Malignant Glioma, Glioblastoma Multiforme | Phase 1 / Phase 2 | Completed | INSYS Therapeutics Inc | 80 | 2002-07-01 | 2011-06-06 |
| Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma IL13-PE38QQR, targeted fusion protein therapy, surgery - Malignant Glioma, Glioblastoma Multiforme | Phase 1 / Phase 2 | Completed | INSYS Therapeutics Inc | 60 | 2000-11-01 | 2014-11-14 |
Astrocytoma (3) · Glioblastoma (3) · Glioma (3) · Neoplasms (1) · Oligodendroglioma (1) · Optic Nerve Glioma (1) · Recurrence (1)
Neoplasms by Histologic Type (3) · Neoplasms, Germ Cell and Embryonal (3) · Neoplasms, Glandular and Epithelial (3) · Neoplasms, Nerve Tissue (3) · Neoplasms, Neuroepithelial (3) · Neuroectodermal Tumors (3) · Neoplasms (2) · Cranial Nerve Diseases (1) · Cranial Nerve Neoplasms (1) · Disease Attributes (1) · Eye Diseases (1) · Neoplasms by Site (1) · Nervous System Diseases (1) · Nervous System Neoplasms (1) · Optic Nerve Diseases (1)
IL13-PE38 (2) · Surgical Procedures, Operative (2) · Doxorubicin (1) · Dynamic Contrast Enhanced Magnetic Resonance Imaging (1) · Etoposide (1) · Perfusion Magnetic Resonance Imaging (1) · etoposide phosphate (1)
INSYS Therapeutics Inc (2) · Washington University School of Medicine (1)
United States (3) · Germany (1) · Israel (1)
Andrew Cluster, M.D. (1) · Jon Weingart, MD (1)